ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1995

Heparan Sulfates from Human Osteoarthritic Cartilage Display Increased Sulfation Pattern, Decrease the Protein Binding Capacity to FGF-2 and Increase the Binding to VEGF and Induce Changes of Human Mesenchymal Stem Cell Behavior

Sarah Shamdani1, Florent Eymard2,3, sandrine Chantepie3, Camille Flageollet1, Nadia Henni-Chebra1, Yoan Jouan1, Eric Hay4, Martine Cohen-Solal5,6,7,8, Dulce Papy-Garcia3, Xavier Chevalier9,10 and Patricia Albanese1, 1Val de Marne, Cell Growth, Tissue Repair and Regeneration Laboratory (CRRET), UPEC EA 4397/ERL CNRS 9215, F-94000, Créteil, France, Créteil, France, 2Department of Rheumatology, APHP Henri Mondor Hospital, Creteil, France, 3Val de Marne, Cell Growth, Tissue Repair and Regeneration Laboratory (CRRET), UPEC EA 4397/ERL CNRS 9215, F-94000, Créteil, France, Creteil, France, 4Rheumatology Department, Lariboisiere Hospital, Inserm UMR-1132, BIOSCAR, Paris, France, 5Paris Diderot University, Paris, France, 6Rhumatologie A, INSERM U606 Hôpital Lariboisière, Centre Viggo Petersen, Paris, France, 7Department of rheumatology and of bone and joint imaging, hospital Lariboisiere, Paris, France, Hôpital Lariboisière, Paris, France, 8INSERM UMR1132, Paris Diderot University, Paris, France, 994, Cell Growth, Tissue Repair and Regeneration Laboratory (CRRET), UPEC EA 4397/ERL CNRS 9215, F-94000, Créteil, France, Creteil, France, 10Rheumatology, Hopital Henri Mondor, APHP, Creteil, France

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: cartilage and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoarthritis and Joint Biology – Basic Science Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

  • The major Glycosaminoglycan (GAGs) component of the cartilage ECM are Chondroitin Sulfates (CS) and Keratan sulfates (KS). Heparan Sulfates (HS) are also present in minority in cartilage and very few studies have been done. In general, However, HS act as central functional regulators of cell behavior, principally because of their capacities to interact with several growth factors.
  • Aim of this study

To characterize the quantity and degree of sulfation of the different GAGs from human normal and osteoarthritic cartilages and to look to the functional properties of HS to bind to growth factors and to induce change on mesenchymal stem cell behavior

Methods:

  • Human samples were harvested from osteoarhritic knee joint (different zones) after TKR and normal counterpart from femoral neck fracture. After extraction, total GAG was quantified by dimethylene blue assay and the proportion of CS, KS and HS were determined following different enzymatic treatments and were normalized to mg of dry tissue. Structure of HS and CS was determined by HPLC analysis. The capacity of the cartilage extracted GAGs to interact with heparin binding proteins such as FGF-2 and VEGF was evaluated by Elisa- based competition assay with heparin. Finally the effect of GAGs on human mesenchymal stem cell ( MSC) was evaluated on adhesion and proliferation assays

Results: 11 OA samples and 7 controlled cartilages were used. Total GAG content was decreased by1.5 fold in OA compared to normal controls. CS level was the same by KS level was decreased and level of HS decreased by 2 fold. The sulfation pattern of HS shows an increase in the % of di-sulfated disaccharides and a 2 fold decrease in non-sulfated HS. Compared to controls, OA total GAG showed a decrease affinity to FGF-2 binding (less 8 fold) and an increase affinity to VEGF (none in control). Those binding affinities were found to be mainly due to purified HS from OA compared to normal cartilages : FGF-2(2.5 fold decrease) and VEGF (3 fold increase). Interestingly in normal controlled cartilage, presence of CS/KS is able to inhibit HS binding to VEGF, while this inhibitory effect is lost in OA cartilage. Treatment with GAGs from controlled cartilage increased cell adhesion and a 30% increase in the cell numbers of MSC in a dose dependent manner. In the same concentration total GAG from OA did not induced any effect

Conclusion: For the first time, this study showed important effects of HS molecules from OA cartilage on growth factors binding and on cell behavior which may participate to the pathological processes of OA.


Disclosure: S. Shamdani, None; F. Eymard, None; S. Chantepie, None; C. Flageollet, None; N. Henni-Chebra, None; Y. Jouan, None; E. Hay, None; M. Cohen-Solal, None; D. Papy-Garcia, None; X. Chevalier, IBSA, 2, 5; P. Albanese, IBSA, 2.

To cite this abstract in AMA style:

Shamdani S, Eymard F, Chantepie S, Flageollet C, Henni-Chebra N, Jouan Y, Hay E, Cohen-Solal M, Papy-Garcia D, Chevalier X, Albanese P. Heparan Sulfates from Human Osteoarthritic Cartilage Display Increased Sulfation Pattern, Decrease the Protein Binding Capacity to FGF-2 and Increase the Binding to VEGF and Induce Changes of Human Mesenchymal Stem Cell Behavior [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/heparan-sulfates-from-human-osteoarthritic-cartilage-display-increased-sulfation-pattern-decrease-the-protein-binding-capacity-to-fgf-2-and-increase-the-binding-to-vegf-and-induce-changes-of-human-me/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/heparan-sulfates-from-human-osteoarthritic-cartilage-display-increased-sulfation-pattern-decrease-the-protein-binding-capacity-to-fgf-2-and-increase-the-binding-to-vegf-and-induce-changes-of-human-me/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology